The labeling procedure itself is performed under clinically sterile conditions. The suspension is injected in 0.3 mL fractions (constraint linked to measurement of the 51Cr activity of the syringes before injection) using 2 mL syringes closed with a stopper. The maximal volume reinjected will be 5 mL by intravenous route.